New AI Research to Help Predict COVID-19 Resource Needs from Series of X-Rays
Scientists have developed machine learning (ML) models that could help doctors predict how a COVID-19 patient’s condition may develop, in order to help hospitals ensure they have sufficient resources to care for patients. More...18 Jan 2021
Researchers Use Natural-Language Processing (NLP) Algorithms to Predict SARS-CoV-2 Virus Mutations
Natural-language processing (NLP) algorithms are now able to generate protein sequences and predict virus mutations, including key changes that help the SARS-CoV-2 virus evade the immune system. More...18 Jan 2021
New DNA Test Quickly Identifies Secondary Infections in COVID-19 Patients with Double Risk of Developing Pneumonia
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients. More...18 Jan 2021
Rapid Blood Test Measures Mitochondrial DNA to Identify COVID-19 Patients Who Will Need ICU Care and Intubation
A relatively simple and rapid blood test can predict - within a day of a hospital admission - which patients with COVID-19 are at highest risk of severe complications or death. More...18 Jan 2021
Groundbreaking Trial Shows Umbilical-Cord Derived Mesenchymal Stem Cell Infusions Save Lives of Sickest COVID-19 Patients
A unique and groundbreaking randomized controlled trial has shown that umbilical-cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients. More...18 Jan 2021
Eurofins Launches New Tests and Massive Capacity for Detecting and Monitoring New Variants of SARS-CoV-2
Eurofins (Luxembourg) has launched various initiatives to support the health authorities’ programs for the detection and monitoring of increasingly diverse SARS-CoV-2 variants. More...18 Jan 2021
Gold Member
12-Channel ECG
CM1200B
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
In-Bed Scale
IBFL500
New
Mini C-arm Imaging System
Fluoroscan InSight FD
In Other News
Innovative Combination of Upper-Room GUV Lights and HEPA Filtration Offers Cost-Effective COVID-19 Control Solution for Hospitals
Machine Learning Tool Gives Early Warning of Cardiac Issues or Blood Clots in COVID Patients
Johnson & Johnson Single-Dose COVID-19 Vaccine Demonstrates Lasting Immune Response in Early-Stage Trials
EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response
PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing
Disposable Helmet Retains Cough Droplets and Decreases Risk of COVID-19 Transmission from Patients
FDA-Approved Patient Isolation Solution Enables Hospitals to Quickly Set Up Emergency Isolation Rooms for COVID-19 Patients
New Nanoparticle Immunization Technology Could Protect Against SARS-CoV-2 and Different Coronavirus Variants
`Immune Cop` Identified in Human Lungs That Detects SARS-CoV-2 Could Help Develop New COVID-19 Treatments
Ortho's VITROS SARS-CoV-2 Antigen Test Becomes First High-Volume COVID-19 Antigen Test to Receive FDA EUA
First-of-Its-Kind COVID-19 Lung CT Lesion Segmentation Grand Challenge Unveils Top 10 Results
Innovative Molecular Detection System Offers On-Site and Rapid Detection of SARS-CoV-2
Distinct Blood Signatures Found in COVID-19 Patients Could Significantly Improve Testing
New Simplified Rapid COVID-19 Testing Protocol Requires Less Labor, Expertise and Equipment
Snibe Diagnostic’s Maglumi SARS-CoV-2 Neutralizing Antibody Assay Receives CE Mark
COVID-19 Survivors Have Immune Cells Necessary to Fight Re-Infection Until Eight Months, Suggests New Data
FDA Monitoring Impact of SARS-CoV-2 Mutations on Results of Authorized COVID-19 Molecular Tests
New Online Risk-Stratification Tool Accurately Predicts Likelihood of Deterioration in Hospitalized COVID-19 Patients
COVID-19 Test Chip Made by Aerosol Jet Nanoparticle 3D Printing Detects SARS-CoV-2 Antibodies in 10-12 Seconds
Pfizer-BioNTech COVID-19 Vaccine Effectively Neutralizes Highly Transmissible SARS-CoV-2 Mutations, Finds New Study
Siemens IL-6 Test for COVID-19 Response Granted FDA Emergency Use Authorization
Seasonal Coronaviruses Might Stimulate Cross-Protection Against SARS-CoV-2, Finds New Study
NIH Develops Robust SARS-CoV-2 Serology ELISAs from Serum and Dried Blood Microsamples
